IRIN Examines Potential Rollout Of HIV/AIDS Vaccine

An IRIN analysis examines how nations need to prepare for the distribution of a future HIV/AIDS vaccine. “Increased attention to the delivery of HIV prevention and treatment programs is needed to prepare communities for a potential rollout of a vaccine, which will most probably be partially effective, experts say,” IRIN writes. The analysis highlights ongoing vaccine research and quotes several experts, including Mitchell Warren, executive director of AVAC; Michael Merson, director of the Global Health Institute at Duke University; Naresh Pratap Kc, director of Nepal’s National Centre for AIDS and Sexually Transmitted Disease Control; and a UNAIDS spokesperson. Those interviewed discuss lessons learned from other vaccines, donor community awareness, HIV testing methods, and the need for outreach to “communities who carry the heaviest burden of HIV risk and infection,” according to IRIN (10/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.